BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2009
View Archived Issues
Interim clinical data reported for SCH-900518 combination regimens
Read More
Pfizer submits Lipitor data to EMEA
Read More
TB-403 shown to be safe in healthy males and cancer patients in phase I trials
Read More
Cel-Sci initiates first clinical study of LEAPS-H1N1 therapy in H1N1
Read More
Mitsubishi Tanabe reports results from quarter ended September 30, 2009
Read More
Schering-Plough reports results from third quarter of 2009
Read More
VALIANT study results suggest increased HR is predictive of worse outcome in post-MI
Read More
Insight into the mechanism of action of ATI-5261, a novel synthetic peptide
Read More
Chymase inhibitor improves left ventricular function after mitral regurgitation
Read More
CytRx to initiate phase II clinical trial of INNO-206 in advanced gastric cancer
Read More
Clinical Data starts phase III Stedivaze trial for cardiac stress testing
Read More
Phase I data analysis triggers clinical advance of Alzheimer's disease vaccine
Read More
Altair Therapeutics initiates multicenter phase IIa trial of AIR-645 in asthma
Read More
First patient cohort enrolled in Dynavax Technologies' phase Ib trial of DV-601 in hepatitis B
Read More
Insulin secretion stimulators described by Merck KGaA for the treatment of hyperglycemia
Read More
BMS claims four series of novel NS5B inhibitors for treatment of HCV infection
Read More
Astellas and XenoPort submit NDA in Japan for ASP-8825 for RLS
Read More
Novel antimitotic agents claimed by Korean scientists for the treatment of cancer
Read More
AstraZeneca claims chemokine CX3CR1 receptor antagonists
Read More
Epiphany Biosciences reports results from phase IIb trial of valomaciclovir in shingles
Read More
Otsuka withdraws its application to EMEA for extended indication of Abilify
Read More
Synairgen completes phase I safety trial of inhaled IFN-beta in asthma
Read More
Jennerex and Lee's enter into license agreement for cancer drug JX-594 in China
Read More
FDA reports new safety information concerning drug-drug interactions with clopidogrel
Read More
Pfizer and DNDi enter research collaboration for drugs against tropical diseases
Read More
Advanced Cell Technology files IND with FDA to initiate phase I/II trial in Stargardt's disease
Read More